Next Investors talking this up today - that's the driver of...

Next Investors talking this up today - that's the driver of volume after a somewhat lackluster response to the results yesterday. I have been particularly absent on this thread for some time while the company just does their thing - they are doing it well all things considered. Funding sorted for now, I like their TGA plan, cheaper to market and generate income to fund a larger trial to FDA (all autism). The other indications all present great upside and are not priced in at all. In better market conditions this would be a $250m company. There appears to be a seller into this volume, it looks very technical at 8c to me. Break through opens up the chart nicely to 10c (recent cap raise). IF it fails to break through, then might have a few weeks to buy in the 7c range before next news. GLTAH.